India panel proposes to regulate prices of patented medicines Reuters The proposal, posted late on Monday on the ministry website, cites as an example the lung-cancer drug erlotinib HCL, sold by Roche Holding AG as Tarceva. In India, it costs 35,450 rupees ($660) for one month of 100 mg tablets, equivalent to 121,085 ... |
